Evidence map›Paper›PMID 34823473›Full record

ArticleBMC bioinformatics2021

TSEBRA: transcript selector for BRAKER.

Lars Gabriel, Katharina J Hoff, Tomáš Brůna, Mark Borodovsky, Mario Stanke

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 270 papers.

0numbers the graph read from it
0cells of the map it votes in
270citing papers in PubMed
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

270 citing papers in PubMed, 350 citations in OpenAlex.

  1. Article
  2. Genome analysis of the glycosphingolipid-producing green alga tetraselmis sp. NKG400013.DNA research : an international journal for rapid publication of reports on genes and genomes · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Evolution of compound eye cell types shapes visual behaviors acrossbioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. A Complete Telomere-To-Telomere Assembly ofEvolutionary applications · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

210 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Lars GabrielInstitute of Mathematics and Computer Science, University of Greifswald, Walther-Rathenau-Str. 47, 17489, Greifswald, Germany.
Katharina J HoffInstitute of Mathematics and Computer Science, University of Greifswald, Walther-Rathenau-Str. 47, 17489, Greifswald, Germany.
Tomáš BrůnaSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
Mark BorodovskyWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
Mario StankeInstitute of Mathematics and Computer Science, University of Greifswald, Walther-Rathenau-Str. 47, 17489, Greifswald, Germany. mario.stanke@uni-greifswald.de.ORCID http://orcid.org/0000-0001-8696-0384
Georgia Institute of Technology · USUniversität Greifswald · DEUniversitätsmedizin Greifswald · DE

Funding

NIGMS Administrative Supplements to Support Undergraduate Summer ResearchR01GM128145 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI BORODOVSKY, MARK · 2018 to 2021
$1.1M
NIGMS NIH HHS R01 GM128145NIH HHS GM128145
6 · The paper itself

Abstract

backgroundBRAKER is a suite of automatic pipelines, BRAKER1 and BRAKER2, for the accurate annotation of protein-coding genes in eukaryotic genomes. Each pipeline trains statistical models of protein-coding genes based on provided evidence and, then predicts protein-coding genes in genomic sequences using both the extrinsic evidence and statistical models. For training and prediction, BRAKER1 and BRAKER2 incorporate complementary extrinsic evidence: BRAKER1 uses only RNA-seq data while BRAKER2 uses only a database of cross-species proteins. The BRAKER suite has so far not been able to reliably exceed the accuracy of BRAKER1 and BRAKER2 when incorporating both types of evidence simultaneously. Currently, for a novel genome project where both RNA-seq and protein data are available, the best option is to run both pipelines independently, and to pick one, likely better output. Therefore, one or another type of the extrinsic evidence would remain unexploited.

resultsWe present TSEBRA, a software that selects gene predictions (transcripts) from the sets generated by BRAKER1 and BRAKER2. TSEBRA uses a set of rules to compare scores of overlapping transcripts based on their support by RNA-seq and homologous protein evidence. We show in computational experiments on genomes of 11 species that TSEBRA achieves higher accuracy than either BRAKER1 or BRAKER2 running alone and that TSEBRA compares favorably with the combiner tool EVidenceModeler.

conclusionTSEBRA is an easy-to-use and fast software tool. It can be used in concert with the BRAKER pipeline to generate a gene prediction set supported by both RNA-seq and homologous protein evidence.

Indexed as

GenomeSoftwareGenomicsRNA-SeqSequence Analysis, RNAEvidence integrationGene predictionGenome annotationProtein-coding genesProtein homologyRNA-seq

Identifiers

PMID34823473
PMCPMC8620231
OpenAlexW3216688351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.